news
Journal points to 'deprescribing' dangers in mental health care
STAT News' Sunny Patel warns that "deprescribing" — the movement to reduce psychiatric medication — is becoming a clinical hazard. Patel argues this trend risks patient well-being when elevated to a default approach without individual assessment and medical oversight.
STAT News' Sunny Patel warns that "deprescribing" — the movement to reduce psychiatric medication — is becoming a clinical hazard. Patel argues this trend risks patient well-being when elevated to a default approach without individual assessment and medical oversight.
The architecture take
The pendulum swings fast. After decades of perhaps over-prescribing psychiatric meds, the push to "deprescribe" everything has gone mainstream. Patel is right; making it a default is a real danger. Cutting meds, especially SSRIs or stimulants, without clinical guidance means messing with your brain chemistry, the delicate balance of dopamine, serotonin, and norepinephrine. It’s not just a lifestyle choice; it’s a biological cascade. You wouldn't arbitrarily stop blood pressure meds, so why mess with the systems that regulate mood, focus, and nervous system resilience? This move often comes from a place of good intent, but without careful management, it threatens to swap one set of problems for a potentially worse one tied to withdrawal and destabilized mental health. The real work is balancing modern pharmacology with nervous system tools, not just ditching one for the other.